Latest Solta Medical Inc (SLTM) Headlines
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cyber Kiosk Solutions Continues To Position Itself In The Forefront Of The Legalized Marijuana Industry By Creating A Mobile E-Wallet App For Smart Phone Users
PR Newswire - Wed Feb 26, 7:30AM CST
Cyber Kiosk Solutions, Inc. (OTC Pink: CYBK) has begun its development of a mobile e-wallet app for smart phone users in the legalized marijuana industry. The Company has fast-tracked the development process and is expected to release the app for testing in dispensaries in the next 30 to 60 days. The mobile app is planned to connect into the Company's age/id verification and fraud prevention software.
Global Anti-Aging Market Report 2013-2019: Anti-Wrinkle, Hair Color, Hair Restoration, Breast Augmentation & Radio Frequency Devices
M2 - Thu Feb 20, 9:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldr8ng/antiaging_market) has announced the addition of the "Global Anti-Aging Market Report 2013-2019: Anti-Wrinkle, Hair Color, Hair Restoration, Breast Augmentation & Radio Frequency Devices" report to their offering. North America is the leading geography for anti-aging market due to high awareness about aging signs, rise in obesity and sedentary lifestyle which are the major drivers of this market. Anti-aging services and products market are observed to be more mature markets than devices but demand for devices for personal use is increasing in this geography. Asia- Pacific market is expected to grow as the acceptance of new product, service or device has been increased over years due to awareness among population of Asia-Pacific and their growing economies have also added up to their disposable income capacities. This report studies the global market for anti-aging products, services and devices along with contributions of different generations in this market. The market is thus segmented on the basis of demographics, products, services and devices. The market for products, services and devices is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD million. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD Million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for anti-aging market. A chapter on recommendations for existing and new entrants is also provided in this report. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Anti-aging Market by Demographics, Size and Forecast, 2011 - 2019 (USD Million) Chapter 5 Global Anti-aging Market by Products, Size and Forecast, 2011-2019 (USD Million) Chapter 6 Global Anti-aging Market, by Services, 2011 - 2019 (USD Million) Chapter 7 Global Anti-aging Market by Devices, Size and Forecast, 2011-2019 (USD Million) Chapter 8 Global Anti-aging Market by Geography, Size and Forecast, 2011-2019 (USD Million) Chapter 9 Recommendations Chapter 10 Company Profiles - Allergan, Inc. - Alma Laser - Beiersdorf AG - Coty Inc. - Cynosure - Lumenis - L'Or?al SA - Personal Microderm (PMD) - Photomedex - Solta Medical, Inc. For more information visit http://www.researchandmarkets.com/research/ld...ing_market
Northrop Grumman's Mike Papay to Discuss Corporate Information Security "Best Practices" at this Year's RSA Conference
PR Newswire - Wed Feb 19, 9:30AM CST
Michael Papay, vice president and chief information security officer (CISO), Northrop Grumman Corporation (NYSE: NOC), will be among a panel of industry-leading CISOs who will discuss the complexities of deploying information security within a large corporate enterprise during the RSA Conference USA 2014, Feb. 24 - 28 at the Moscone Center in San Francisco.
WegoWise and Steven Winter Associates Unveil Integrated Multifamily Benchmarking Service
PR Newswire - Tue Feb 04, 7:55AM CST
Building intelligence provider, WegoWise, and Steven Winter Associates, Inc., a leading energy and sustainability consulting firm, have announced a partnership created to offer a new service for benchmarking in multifamily buildings. The service combines utility data analysis and auditing services to help New York property owners comply with Local Law 84 energy disclosure mandates. In addition, it will also enable owners to easily tap collected utility data to identify high-impact building retrofits and achieve dramatic savings.
Concise Analysis on the International Skincare Devices Market - Forecasts to 2018
M2 - Thu Jan 30, 4:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/xdr3vq/skincare_devices) has announced the addition of the "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018" report to their offering. "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018", studies the market for skincare devices from two aspects, the different product types and applications. Each of these segments has been further divided into sub-segments; the products segment has been categorized into diagnostic and treatment devices. Diagnostic devices include dermatoscopes, biopsy devices and image guidance systems whereas treatment devices comprise of lasabrasion devices, microdermabrasion devices, liposuction devices, electrosurgical devices, cryotherapy devices and LED therapy devices. Market size and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments, in terms of USD million, considering 2011 as the base year. The % CAGR for each market segment for the forecast period has been provided along with market size estimations. The market has been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section features a detailed analysis of factors such as drivers, restraints and opportunities that affect the market dynamics, along with market attractiveness analysis and Porter's five force analysis for the skincare devices market. The competitive landscape section includes market share analysis of all the leading players in this market, in terms of percentage share in the year 2011. Some of the major players profiled in this report include Alma Lasers Ltd., Cynosure, Inc., Cutera, Inc., PhotoMedex, Inc., Solta Medical Ltd. and Syneron Medical. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Global Skincare Devices Market, by Product Type 5 Global Skincare Devices Market, by Application 6 Global Skincare Devices Market, by Geography 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - Alma Lasers - Cutera - Cynosure - Lumenis - Michelson Diagnostics - Palomar Medical Technologies - Photomedex - Solta Medical - Syneron Medical For more information visit http://www.researchandmarkets.com/research/xd...re_devices
BBVA Compass appoints fifth member to its San Antonio advisory board
PR Newswire - Wed Jan 29, 2:39PM CST
Automotive manufacturing business executive Jason Reyes has joined BBVA Compass' San Antonio advisory board.
Valeant Pharmaceuticals International Inc acquires Solta Medical Inc at USD2.92 per share cash
M2 - Fri Jan 24, 4:59AM CST
Pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE:VRX) (TSX:VRX) stated on Thursday that it has acquired all outstanding common shares of Solta Medical Inc (SLTM) at a price of USD2.92 per share in cash.
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta Medical, Inc.
PR Newswire - Thu Jan 23, 4:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International ("VPI") would acquire Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") at a price of $2.92 per share in cash, or approximately $250 million in the aggregate.
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Solta Medical, Inc.
PR Newswire - Thu Jan 23, 7:47AM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ("VPI") to purchase all of the outstanding shares of Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") for a price of $2.92 per share in cash, without interest (less any applicable withholding taxes).
Solta Medical, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Fri Jan 17, 10:53AM CST
Securities lawyers at Deans & Lyons announce an investigation of the board of Solta Medical, Inc. (NASDAQ: SLTM) in connection with a buyout for $2.92 per share. Concerned SLTM investors are encouraged to contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.
Technical Update on Health Care Sector: Solta Medical, Orexigen Therapeutics, Vertex Pharmaceuticals, and Alere
PR Newswire - Thu Jan 16, 6:58AM CST
Editor Note: For more information about this release, please scroll to bottom.
Valeant Pharmaceuticals wins Antitrust Clearance for acquisition of Solta Medical Inc
M2 - Thu Jan 16, 4:51AM CST
Pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE:VRX)(TSX:VRX) reported on Wednesday that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with respect to the tender offer for all of the outstanding common shares of Solta Medical Inc (SLTM) expired at Midnight, New York City time on 14 January 2014.
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
PR Newswire - Wed Jan 15, 7:00AM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all of the outstanding shares of common stock of Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") at a price of $2.92 per share, net to the seller in cash, without interest (less any required withholding taxes) and subsequent merger of Purchaser with Solta expired at 11:59 p.m., New York City time on January 14, 2014. The expiration of the HSR waiting period satisfies one of the conditions to consummate the tender offer.
Photo Release -- NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek, Solta Medical Chairman and CEO and Dr. Massimo Radaelli, Noventia Pharma CEO to Its Board of Directors
GlobeNewswire - Thu Jan 09, 7:30AM CST
Combined Total of Over 50 Years of Healthcare Experience in Global Markets Adds Significant Depth to NovaBay's Board
Why Valeant Pharmaceuticals Intl. Inc. Shares Popped
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 07, 12:56PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Valeant Pharmaceuticals shot higher by as...
Valeant Attains 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 9:10AM CST
Shares of Valeant Pharma reached a 52-week high of $118.25 during the course of the trading session on Dec 31, 2013
Ambarella, Jazz Among Stocks Outpacing Record Market
at Investor's Business Daily - Tue Dec 31, 7:02AM CST
The "Santa Claus rally" has sent stocks to new heights, but Zeltiq Aesthetics (ZLTQ), Ambarella (AMBA), WuXi Pharmatech (WX) and Jazz Pharmaceuticals (JAZZ) are outperforming the record-setting market. IBD's Bolting Relative Strength Lines Screen of...
Program Participations and Positive Stock Movements - Research Report on Life Technologies, Covance, HB Fuller, Solta Medical, and NuPathe
PR Newswire - Tue Dec 31, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Lifshitz Law Firm Announces Investigation of Coleman Cable, Inc., NuPathe Inc., Solta Medical, Inc., The Jones Group Inc. and Tufco Technologies, Inc.
PR Newswire - Mon Dec 30, 5:45PM CST
Coleman Cable, Inc.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Cyber Kiosk Solutions Continues To Position Itself In The Forefront Of The Legalized Marijuana Industry By Creating A Mobile E-Wallet App For Smart Phone Users
PR Newswire - Wed Feb 26, 7:30AM CST
Cyber Kiosk Solutions, Inc. (OTC Pink: CYBK) has begun its development of a mobile e-wallet app for smart phone users in the legalized marijuana industry. The Company has fast-tracked the development process and is expected to release the app for testing in dispensaries in the next 30 to 60 days. The mobile app is planned to connect into the Company's age/id verification and fraud prevention software.
Global Anti-Aging Market Report 2013-2019: Anti-Wrinkle, Hair Color, Hair Restoration, Breast Augmentation & Radio Frequency Devices
M2 - Thu Feb 20, 9:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldr8ng/antiaging_market) has announced the addition of the "Global Anti-Aging Market Report 2013-2019: Anti-Wrinkle, Hair Color, Hair Restoration, Breast Augmentation & Radio Frequency Devices" report to their offering. North America is the leading geography for anti-aging market due to high awareness about aging signs, rise in obesity and sedentary lifestyle which are the major drivers of this market. Anti-aging services and products market are observed to be more mature markets than devices but demand for devices for personal use is increasing in this geography. Asia- Pacific market is expected to grow as the acceptance of new product, service or device has been increased over years due to awareness among population of Asia-Pacific and their growing economies have also added up to their disposable income capacities. This report studies the global market for anti-aging products, services and devices along with contributions of different generations in this market. The market is thus segmented on the basis of demographics, products, services and devices. The market for products, services and devices is also analyzed for four major geographic regions namely North America, Europe, Asia and the rest of the world (RoW) regions. The markets for all these segments is analyzed and estimated in USD million. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD Million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report for anti-aging market. A chapter on recommendations for existing and new entrants is also provided in this report. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Anti-aging Market by Demographics, Size and Forecast, 2011 - 2019 (USD Million) Chapter 5 Global Anti-aging Market by Products, Size and Forecast, 2011-2019 (USD Million) Chapter 6 Global Anti-aging Market, by Services, 2011 - 2019 (USD Million) Chapter 7 Global Anti-aging Market by Devices, Size and Forecast, 2011-2019 (USD Million) Chapter 8 Global Anti-aging Market by Geography, Size and Forecast, 2011-2019 (USD Million) Chapter 9 Recommendations Chapter 10 Company Profiles - Allergan, Inc. - Alma Laser - Beiersdorf AG - Coty Inc. - Cynosure - Lumenis - L'Or?al SA - Personal Microderm (PMD) - Photomedex - Solta Medical, Inc. For more information visit http://www.researchandmarkets.com/research/ld...ing_market
Northrop Grumman's Mike Papay to Discuss Corporate Information Security "Best Practices" at this Year's RSA Conference
PR Newswire - Wed Feb 19, 9:30AM CST
Michael Papay, vice president and chief information security officer (CISO), Northrop Grumman Corporation (NYSE: NOC), will be among a panel of industry-leading CISOs who will discuss the complexities of deploying information security within a large corporate enterprise during the RSA Conference USA 2014, Feb. 24 - 28 at the Moscone Center in San Francisco.
WegoWise and Steven Winter Associates Unveil Integrated Multifamily Benchmarking Service
PR Newswire - Tue Feb 04, 7:55AM CST
Building intelligence provider, WegoWise, and Steven Winter Associates, Inc., a leading energy and sustainability consulting firm, have announced a partnership created to offer a new service for benchmarking in multifamily buildings. The service combines utility data analysis and auditing services to help New York property owners comply with Local Law 84 energy disclosure mandates. In addition, it will also enable owners to easily tap collected utility data to identify high-impact building retrofits and achieve dramatic savings.
Concise Analysis on the International Skincare Devices Market - Forecasts to 2018
M2 - Thu Jan 30, 4:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/xdr3vq/skincare_devices) has announced the addition of the "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018" report to their offering. "Concise Analysis on the International Skincare Devices Market - Forecasts to 2018", studies the market for skincare devices from two aspects, the different product types and applications. Each of these segments has been further divided into sub-segments; the products segment has been categorized into diagnostic and treatment devices. Diagnostic devices include dermatoscopes, biopsy devices and image guidance systems whereas treatment devices comprise of lasabrasion devices, microdermabrasion devices, liposuction devices, electrosurgical devices, cryotherapy devices and LED therapy devices. Market size and forecasts for the period 2010 - 2018 have been provided for each of the segments and sub-segments, in terms of USD million, considering 2011 as the base year. The % CAGR for each market segment for the forecast period has been provided along with market size estimations. The market has been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section features a detailed analysis of factors such as drivers, restraints and opportunities that affect the market dynamics, along with market attractiveness analysis and Porter's five force analysis for the skincare devices market. The competitive landscape section includes market share analysis of all the leading players in this market, in terms of percentage share in the year 2011. Some of the major players profiled in this report include Alma Lasers Ltd., Cynosure, Inc., Cutera, Inc., PhotoMedex, Inc., Solta Medical Ltd. and Syneron Medical. Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 Global Skincare Devices Market, by Product Type 5 Global Skincare Devices Market, by Application 6 Global Skincare Devices Market, by Geography 7 Competitive Landscape 8 Recommendations 9 Company Profiles Companies Mentioned: - Alma Lasers - Cutera - Cynosure - Lumenis - Michelson Diagnostics - Palomar Medical Technologies - Photomedex - Solta Medical - Syneron Medical For more information visit http://www.researchandmarkets.com/research/xd...re_devices
BBVA Compass appoints fifth member to its San Antonio advisory board
PR Newswire - Wed Jan 29, 2:39PM CST
Automotive manufacturing business executive Jason Reyes has joined BBVA Compass' San Antonio advisory board.
Valeant Pharmaceuticals International Inc acquires Solta Medical Inc at USD2.92 per share cash
M2 - Fri Jan 24, 4:59AM CST
Pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE:VRX) (TSX:VRX) stated on Thursday that it has acquired all outstanding common shares of Solta Medical Inc (SLTM) at a price of USD2.92 per share in cash.
Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Solta Medical, Inc.
PR Newswire - Thu Jan 23, 4:00PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the completion of the previously announced transaction in which a wholly-owned subsidiary of Valeant Pharmaceuticals International ("VPI") would acquire Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") at a price of $2.92 per share in cash, or approximately $250 million in the aggregate.
Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Solta Medical, Inc.
PR Newswire - Thu Jan 23, 7:47AM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ("VPI") to purchase all of the outstanding shares of Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") for a price of $2.92 per share in cash, without interest (less any applicable withholding taxes).
Solta Medical, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR Newswire - Fri Jan 17, 10:53AM CST
Securities lawyers at Deans & Lyons announce an investigation of the board of Solta Medical, Inc. (NASDAQ: SLTM) in connection with a buyout for $2.92 per share. Concerned SLTM investors are encouraged to contact attorney Hamilton Lindley at 877-819-8033 or hlindley@deanslyons.com about their rights and remedies.
Technical Update on Health Care Sector: Solta Medical, Orexigen Therapeutics, Vertex Pharmaceuticals, and Alere
PR Newswire - Thu Jan 16, 6:58AM CST
Editor Note: For more information about this release, please scroll to bottom.
Valeant Pharmaceuticals wins Antitrust Clearance for acquisition of Solta Medical Inc
M2 - Thu Jan 16, 4:51AM CST
Pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE:VRX)(TSX:VRX) reported on Wednesday that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with respect to the tender offer for all of the outstanding common shares of Solta Medical Inc (SLTM) expired at Midnight, New York City time on 14 January 2014.
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
PR Newswire - Wed Jan 15, 7:00AM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all of the outstanding shares of common stock of Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") at a price of $2.92 per share, net to the seller in cash, without interest (less any required withholding taxes) and subsequent merger of Purchaser with Solta expired at 11:59 p.m., New York City time on January 14, 2014. The expiration of the HSR waiting period satisfies one of the conditions to consummate the tender offer.
Photo Release -- NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek, Solta Medical Chairman and CEO and Dr. Massimo Radaelli, Noventia Pharma CEO to Its Board of Directors
GlobeNewswire - Thu Jan 09, 7:30AM CST
Combined Total of Over 50 Years of Healthcare Experience in Global Markets Adds Significant Depth to NovaBay's Board
Why Valeant Pharmaceuticals Intl. Inc. Shares Popped
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 07, 12:56PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Valeant Pharmaceuticals shot higher by as...
Valeant Attains 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 02, 9:10AM CST
Shares of Valeant Pharma reached a 52-week high of $118.25 during the course of the trading session on Dec 31, 2013
Ambarella, Jazz Among Stocks Outpacing Record Market
at Investor's Business Daily - Tue Dec 31, 7:02AM CST
The "Santa Claus rally" has sent stocks to new heights, but Zeltiq Aesthetics (ZLTQ), Ambarella (AMBA), WuXi Pharmatech (WX) and Jazz Pharmaceuticals (JAZZ) are outperforming the record-setting market. IBD's Bolting Relative Strength Lines Screen of...
Program Participations and Positive Stock Movements - Research Report on Life Technologies, Covance, HB Fuller, Solta Medical, and NuPathe
PR Newswire - Tue Dec 31, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.
Lifshitz Law Firm Announces Investigation of Coleman Cable, Inc., NuPathe Inc., Solta Medical, Inc., The Jones Group Inc. and Tufco Technologies, Inc.
PR Newswire - Mon Dec 30, 5:45PM CST
Coleman Cable, Inc.
